Motor and Cognitive Delay in Duchenne Muscular Dystrophy: Implication for Early Diagnosis

被引:44
作者
Mirski, Kara T. [1 ]
Crawford, Thomas O. [2 ,3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ Hosp, Dept Pediat, Baltimore, MD 21287 USA
关键词
D O I
10.1016/j.jpeds.2014.07.006
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives To examine the relationship between delay in the age of first independent walking and cognitive impairment in boys with Duchenne muscular dystrophy (DMD) to assess how age of diagnosis might be improved. Study design We reviewed the records of 179 boys with DMD evaluated by the senior author between 1989 and June 2012. Delay in walking was defined as occurring at or greater than 16 months of age. Cognitive impairment was identified by school placement in special education or lower than expected grade level during the elementary school years. Results Delay in walking and cognitive impairment are highly correlated (P <= .0001). If cognitively delayed, boys with DMD were 3 times more likely to have a delay in walking. This association was shown to be independent from the rate of motor degeneration (P = .9) and the age of diagnosis (P = .6, combined average = 5.1 +/- 2 years). Conclusion Delay in the onset of walking in boys with DMD is strongly associated with cognitive delay. We suspect that primary care givers overlook DMD as a possible cause of delay in the age of independent walking when early features of cognitive delay are also apparent. DMD should be included among those disorders causing global developmental delay. Recognition of this association could substantially decrease the age of diagnosis for many boys with DMD. We suggest that the standard evaluation for boys with global developmental delay include an inexpensive and sensitive serum creatine kinase test.
引用
收藏
页码:1008 / 1010
页数:3
相关论文
共 8 条
[1]  
Arcara K, 2012, HARRIETT LANE HDB MA
[2]   Splicing therapy for neuromuscular disease [J].
Douglas, Andrew G. L. ;
Wood, Matthew J. A. .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2013, 56 :169-185
[3]  
Emery A.E., 2003, DUCHENNE MUSCULAR DY, V3rd
[4]  
KLATT EC, 1982, AM J CLIN PATHOL, V77, P280
[5]   Early prednisone treatment in Duchenne muscular dystrophy [J].
Merlini, L ;
Cicognani, A ;
Malaspina, E ;
Gennari, M ;
Gnudi, S ;
Talim, B ;
Franzoni, E .
MUSCLE & NERVE, 2003, 27 (02) :222-227
[6]  
Romitti P., 2009, Morbidity and Mortality Weekly Report, V58, P1119
[7]   Practice parameter: Evaluation of the child with global developmental delay - Report of the quality standards subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society [J].
Shevell, M ;
Ashwal, S ;
Donley, D ;
Flint, J ;
Gingold, M ;
Hirtz, D ;
Majnemer, A ;
Noetzel, M ;
Sheth, RD .
NEUROLOGY, 2003, 60 (03) :367-380
[8]  
US Department of Health and Human Service: Agency for Healthcare Research and Quality, DIAGN MAN DUCH MUSC